Fig. 1 · Structure
Documents & Downloads
Riamilovir
Antiviral Drug
Riamilovir is an antiviral agent that targets RNA viruses by inhibiting RNA-dependent RNA polymerase, crucial for viral replication. This mechanism significantly decreases viral load, alleviates symptoms, and mitigates disease severity. Riamilovir is particularly valuable in research focused on acute respiratory viral infections, including emerging strains of SARS-CoV-2.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 123606-06-4 |
| Applications | Antiviral Drug |
| Formula | C5H4N6O3S |
| Molecular Weight | 228.19 |
| SMILES | O=C1N(N=C(SC)N2)C2=NN=C1[N+]([O-])=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.